Completed
TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
NCT00146211
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +23 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- University of California San Diego La Jolla, California, United States
- UCLA Medical Center Los Angeles, California, United States